Literature DB >> 16408126

Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease.

M Briet1, E Bozec, S Laurent, C Fassot, G M London, C Jacquot, M Froissart, P Houillier, P Boutouyrie.   

Abstract

Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular morbidity and mortality. Arterial stiffness and remodeling have been well documented in patients with end-stage renal disease, but little is known about arterial phenotype in CKD patients with moderate reduction in glomerular filtration rate (GFR). In total, 95 patients (58+/-15 years, mean+/-s.d.) with CKD and GFR measured by renal clearance of (51)Cr-ethylenediaminetetraacetate were compared to 121 hypertensive patients without CKD (59+/-11 years), and 57 normotensive subjects (56+/-6 years). Common carotid artery diameter, intima-media thickness (IMT), distensibility, and Young's elastic modulus were noninvasively determined with a high-definition echotracking system. Patients with CKD had a significantly larger carotid internal diameter than in hypertensives and normotensives (6.32+/-1.05, 5.84+/-0.74, and 5.50+/-0.64 m x 10(-3), respectively; P<0.001), resulting in 25% and 11% increases in circumferential wall stress, respectively, since no significant difference in IMT was observed. Carotid distensibility and elastic modulus did not significantly differ between CKD and hypertensives; normotensives had significantly higher distensibility and lower elastic modulus than CKD and hypertensive patients. Carotid-femoral pulse wave velocity was significantly higher in CKD patients than in hypertensives and normotensives. In multivariate analyses either involving the entire population or restricted to CKD patients, GFR was independently and strongly related to carotid diameter and elastic modulus. Arterial enlargement and increased arterial stiffness occur in parallel with the decline in renal function in patients with mild-to-moderate CKD.

Entities:  

Mesh:

Year:  2006        PMID: 16408126     DOI: 10.1038/sj.ki.5000047

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  88 in total

1.  Reduced renal function is associated with combined increases in ventricular-systolic stiffness and arterial load in patients undergoing cardiac catheterization for coronary artery disease.

Authors:  Hidekatsu Fukuta; Nobuyuki Ohte; Kazuaki Wakami; Kaoru Asada; Toshihiko Goto; Seiji Mukai; Genjiro Kimura
Journal:  Heart Vessels       Date:  2010-10-16       Impact factor: 2.037

2.  Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes.

Authors:  C Delles; A G Jardine
Journal:  Diabetologia       Date:  2010-10-13       Impact factor: 10.122

3.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

Review 4.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

5.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carmen A Peralta; David R Jacobs; Ronit Katz; Joachim H Ix; Magdalena Madero; Daniel A Duprez; Mark J Sarnak; Michael H Criqui; Holly J Kramer; Walter Palmas; David Herrington; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-10-14       Impact factor: 8.860

6.  Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.

Authors:  Kristen L Nowak; Berenice Gitomer; Heather Farmer-Bailey; Wei Wang; Mikaela Malaczewski; Jelena Klawitter; Zhiying You; Diana George; Nayana Patel; Anna Jovanovich; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2019-02-23       Impact factor: 8.860

Review 7.  Arterial stiffness: is it ready for prime time?

Authors:  Stanley S Franklin
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

8.  Atheroma progression in chronic kidney disease.

Authors:  Claudio Rigatto; Adeera Levin; Andrew A House; Brendan Barrett; Euan Carlisle; Adrian Fine
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 8.237

9.  Arterial Stiffness and Chronic Kidney Disease.

Authors:  Anne-Sophie Garnier; Marie Briet
Journal:  Pulse (Basel)       Date:  2016-03-01

10.  Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anh L Bui; Ronit Katz; Bryan Kestenbaum; Ian H de Boer; Linda F Fried; Joseph F Polak; Bruce A Wasserman; Mark J Sarnak; David Siscovick; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.